Annual report pursuant to Section 13 and 15(d)

12. SEGMENTS (Details)

v3.8.0.1
12. SEGMENTS (Details) - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Revenues $ 22,760,560 $ 10,661,037
Cost of product revenue 29,164,321 6,360,761
Gross (loss) profit (6,403,761) 4,300,276
Loss from operations (39,309,996) (17,330,395)
Interest and other expense, net (4,448,979) (2,184,756)
Net loss (43,758,975) (19,515,151)
Capital expenditures 2,676,328 73,410
Depreciation and amortization expense 2,692,301 469,576
Total assets 108,018,833 23,685,085
ADMA BioManufacturing    
Revenues 10,980,987 0
Cost of product revenue 21,862,140 0
Gross (loss) profit (10,881,153) 0
Loss from operations (19,801,455) 0
Interest and other expense, net (537,235) 0
Net loss (20,338,690) 0
Capital expenditures 747,402 0
Depreciation and amortization expense 2,204,772 0
Total assets 54,004,696 0
Plasma Collection Centers [Member]    
Revenues 11,636,739 10,518,203
Cost of product revenue 7,302,181 6,360,761
Gross (loss) profit 4,334,558 4,157,442
Loss from operations (2,169,192) (1,290,249)
Interest and other expense, net (6,885) 0
Net loss (2,176,077) (1,290,249)
Capital expenditures 1,913,663 56,328
Depreciation and amortization expense 436,687 414,464
Total assets 3,933,673 2,421,535
Corporate [Member]    
Revenues 142,834 142,834
Cost of product revenue 0 0
Gross (loss) profit 142,834 142,834
Loss from operations (17,339,349) (16,040,146)
Interest and other expense, net (3,904,859) (2,184,756)
Net loss (21,244,208) (18,224,902)
Capital expenditures 15,263 17,082
Depreciation and amortization expense 50,842 55,112
Total assets $ 50,080,464 $ 21,263,550